MX9801814A - Nuevas 4-(oxialcoxifenil)-3-oxi-piperidinas para el tratamiento de la insuficiencia del corazon y renal. - Google Patents

Nuevas 4-(oxialcoxifenil)-3-oxi-piperidinas para el tratamiento de la insuficiencia del corazon y renal.

Info

Publication number
MX9801814A
MX9801814A MX9801814A MX9801814A MX9801814A MX 9801814 A MX9801814 A MX 9801814A MX 9801814 A MX9801814 A MX 9801814A MX 9801814 A MX9801814 A MX 9801814A MX 9801814 A MX9801814 A MX 9801814A
Authority
MX
Mexico
Prior art keywords
new
oxyalkoxyphenyl
piperidines
oxy
treating heart
Prior art date
Application number
MX9801814A
Other languages
English (en)
Other versions
MXPA98001814A (es
Inventor
Alfred Binggeli
Volker Breu
Daniel Bur
Walter Fischli
Rolf Gueller
Georges Hirth
Hans-Peter Maerki
Marcel Mueller
Christian Oefner
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX9801814A publication Critical patent/MX9801814A/es
Publication of MXPA98001814A publication Critical patent/MXPA98001814A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/42Oxygen atoms attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Abstract

La invencion se relaciona a nuevos derivados de piperidina de la formula general I (Ver Formula) en donde R1, R2, R3, R4, Q, W, X, Z, m y n tienen el significado expuesto en la especificacion. Los nuevos derivados de piperidina pueden utilizarse como inhibidores de resina en el control o prevencion de hipertension e insuficiencia cardiaca, así como glaucoma, infarto cardiaco, insuficiencia renal y restonosis.
MXPA/A/1998/001814A 1995-09-07 1998-03-06 Nuevas 4-(oxialcoxifenil)-3-oxi-piperidinas para el tratamiento de la insuficiencia del corazon y renal MXPA98001814A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH2548/95-1 1995-09-07
CH254895 1995-09-07
CH1876/96 1996-07-26
CH187696 1996-07-26

Publications (2)

Publication Number Publication Date
MX9801814A true MX9801814A (es) 1998-08-30
MXPA98001814A MXPA98001814A (es) 1998-11-12

Family

ID=

Also Published As

Publication number Publication date
HUP9900926A3 (en) 2002-12-28
CY2488B1 (en) 2005-06-03
DE59610509D1 (de) 2003-07-10
WO1997009311A1 (de) 1997-03-13
TR199800409T1 (xx) 1998-05-21
RU2167865C2 (ru) 2001-05-27
US6051712A (en) 2000-04-18
NO980954L (no) 1998-04-28
CZ292327B6 (cs) 2003-09-17
CN1202152A (zh) 1998-12-16
CA2230931A1 (en) 1997-03-13
PL193686B1 (pl) 2007-03-30
NZ315677A (en) 2000-02-28
EP0863875B1 (de) 2003-06-04
JP3648251B2 (ja) 2005-05-18
EP0863875A1 (de) 1998-09-16
JPH11500447A (ja) 1999-01-12
ES2201192T3 (es) 2004-03-16
AU6743296A (en) 1997-03-27
NO980954D0 (no) 1998-03-05
US6150526A (en) 2000-11-21
CZ68498A3 (cs) 1998-10-14
TW474932B (en) 2002-02-01
CA2230931C (en) 2009-05-19
SA96170317B1 (ar) 2006-05-13
KR100384979B1 (ko) 2003-10-17
HK1016177A1 (en) 1999-10-29
KR19990044459A (ko) 1999-06-25
AU708616B2 (en) 1999-08-05
MA23967A1 (fr) 1997-04-01
MY121967A (en) 2006-03-31
ATE242213T1 (de) 2003-06-15
BR9610385A (pt) 1999-07-06
PT863875E (pt) 2003-10-31
IL123293A (en) 2003-06-24
IL123293A0 (en) 1998-09-24
HUP9900926A2 (hu) 1999-09-28
DK0863875T3 (da) 2003-12-01
CN1256326C (zh) 2006-05-17
NO310069B1 (no) 2001-05-14
PL325425A1 (en) 1998-07-20

Similar Documents

Publication Publication Date Title
HUP9900926A2 (hu) Új (4-oxialkoxi-fenil)-3-oxi-piperidinek, szív- és veseelégtelenség kezelésére
DE69531457D1 (en) Sulfonamide
MX9706069A (es) Nuevos inhibidores de la trombina.
TR200200205T2 (tr) MEK inhibitörleri kullanılarak kronik ağrının tedavi edilmesi
NO975716L (no) Imidazolforbindelser
HK1023987A1 (en) Sulphinic acid derivatives, method for producing, and their use
MX9700430A (es) El uso de compuestos heterociclicos.
NO20075066L (no) Farmasoytisk sammensetning som inneholder isoflavoner
MX9606521A (es) Inhibidores de trombina novedosos, preparacion y uso de los mismos.
MY121548A (en) Compounds and methods for the treatment of cancer
TR200200068T2 (tr) Nematisital triflüorobütenler
AP9701007A0 (en) Substituted azetidin-2-ones for treatment of atherosclerosis.
YU48698A (sh) Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze
NZ332096A (en) Alpha-hydroxylic acid derivatives their production and use in treating conditions requiring endothelin inhibition
NO995431L (no) Substituerte 3,3-diamino-2-propennitriler, deres fremstilling og anvendelse
GB2324091B (en) Metalloproteinase inhibitors
NO961333L (no) Nye pyrazolderivater som angiotensin-II-antagonister
MXPA03004879A (es) Inhibidores de farnesiltransferasa.
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
MX9801133A (es) Agente endoparasiticida a base de didepsipeptidos, nuevos didepsipeptidos y procedimiento para su produccion.
NZ511997A (en) Isonipecotamides for the treatment of integrin-mediated disorders
SE9602145D0 (sv) New improved formulation for treatment of thromboembolism
SI0937075T1 (en) New Imidazo- and Oxazolopyridines as Phosphodiesterase Inhibitors.
TW271437B (es)

Legal Events

Date Code Title Description
FG Grant or registration